注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
European Biotech Acquisition Corp是一家荷兰的空白支票公司。该公司成立的目的是进行合并、股份交换、资产收购、股份购买、重组或一个或多个业务或公司与类似业务合并。该公司打算主要在欧洲生命科学领域寻求目标公司。它专注于在包括肿瘤学、糖尿病、心脏病学、中枢神经系统(CNS)和罕见疾病在内的各种治疗领域临床开发中对候选治疗药物进行投资。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Quan Dong Nguyen | - | 2022 | Member of Scientific Advisory Board |
Peter K. Kaiser | - | 2022 | Member of Scientific Advisory Board |
Kuldev Singh | - | - | Member of Scientific Advisory Board |
Anat Loewenstein | - | 2022 | Member of Scientific Advisory Board |
Pablo Villoslada | - | 2022 | Member of Scientific Advisory Board |
Anthony A. Rosenberg | 71 | 2018 | Independent Chairman |
Riad Sherif | 56 | 2017 | CEO & Director |
Martijn Kleijwegt | 69 | 2023 | Independent Director |
Lionel Carnot | 57 | 2017 | Independent Director |
Christophe Baudouin | 63 | 2022 | Member of Scientific Advisory Board |
Arshad M. Khanani | - | 2022 | Chair of Retina Scientific Advisory Board |
Christina M. Ackermann | 59 | 2023 | Independent Director |
Pravin U. Dugel | 60 | 2023 | Independent Director |
Eric D. Donnenfeld | 68 | - | Chair of Cornea Scientific Advisory Board |
David S. Boyer | - | 2024 | Member of Scientific Advisory Board |
Geraldine O'Keeffe | - | 2023 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核